The Latin America, Middle East and Africa Ruminant Vaccines Market would witness market growth of 9.1% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $131.5 million by 2031. The Argentina market is showcasing a CAGR of 9.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 8.7% during (2024 - 2031).
Knowledge, awareness, and education are critical in driving producers’ adoption of vaccination programs. Access to information about disease risks, vaccine efficacy, vaccination protocols, and best practices in herd health management empowers producers to make informed decisions about disease prevention strategies and vaccine use. Moreover, access to veterinary services, vaccine products, and support infrastructure influences the adoption of vaccination programs in ruminant populations.
Producers in remote or underserved areas may face challenges in accessing veterinary care, vaccine supplies, and technical expertise, which can impact their ability to implement vaccination effectively. The availability of cold chain infrastructure, vaccination equipment, and storage facilities affects vaccine delivery and administration in ruminant populations. Producers prioritize investment in infrastructure and logistics to ensure the quality and efficacy of vaccines and optimize vaccine coverage rates.
Leptospirosis is a widespread and economically significant bacterial disease affecting ruminants in Brazil. According to the National Library of Medicine, Brazil has the highest number of reported cases of leptospirosis in the region of the Americas. An average of 4,000 confirmed cases with a 10% case fatality are reported to the Ministry of Health (MOH). Most cases are among young adults between the ages of 20 and 49 years old. The high prevalence of leptospirosis drives the demand for effective vaccines among cattle producers in Brazil. Likewise, the UAE has many livestock, including sheep, goats, and camels. These animals are susceptible to various infectious diseases, including respiratory infections, gastrointestinal diseases, and vector-borne illnesses. A substantial number of cattle are present in the United Arab Emirates, according to the Ministry of Climate Change & Environment. It is estimated that 450,000 camels are present across the nation overall. In contrast, sheep and goat herds are estimated at 5 million, thus constituting an important component of food security and the national economy. Therefore, the high population of livestock and the prevalence of leptospirosis are driving the market's growth.
Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The Brazil market dominated the LAMEA Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $131.5 million by 2031. The Argentina market is showcasing a CAGR of 9.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 8.7% during (2024 - 2031).
Knowledge, awareness, and education are critical in driving producers’ adoption of vaccination programs. Access to information about disease risks, vaccine efficacy, vaccination protocols, and best practices in herd health management empowers producers to make informed decisions about disease prevention strategies and vaccine use. Moreover, access to veterinary services, vaccine products, and support infrastructure influences the adoption of vaccination programs in ruminant populations.
Producers in remote or underserved areas may face challenges in accessing veterinary care, vaccine supplies, and technical expertise, which can impact their ability to implement vaccination effectively. The availability of cold chain infrastructure, vaccination equipment, and storage facilities affects vaccine delivery and administration in ruminant populations. Producers prioritize investment in infrastructure and logistics to ensure the quality and efficacy of vaccines and optimize vaccine coverage rates.
Leptospirosis is a widespread and economically significant bacterial disease affecting ruminants in Brazil. According to the National Library of Medicine, Brazil has the highest number of reported cases of leptospirosis in the region of the Americas. An average of 4,000 confirmed cases with a 10% case fatality are reported to the Ministry of Health (MOH). Most cases are among young adults between the ages of 20 and 49 years old. The high prevalence of leptospirosis drives the demand for effective vaccines among cattle producers in Brazil. Likewise, the UAE has many livestock, including sheep, goats, and camels. These animals are susceptible to various infectious diseases, including respiratory infections, gastrointestinal diseases, and vector-borne illnesses. A substantial number of cattle are present in the United Arab Emirates, according to the Ministry of Climate Change & Environment. It is estimated that 450,000 camels are present across the nation overall. In contrast, sheep and goat herds are estimated at 5 million, thus constituting an important component of food security and the national economy. Therefore, the high population of livestock and the prevalence of leptospirosis are driving the market's growth.
Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
Market Report Segmentation
By Animal Type- Cattle
- Sheep & Goats
- Modified/ Attenuated Live
- Inactivated (Killed)
- Others
- Injectable
- Intranasal
- Bovine Respiratory Diseases (BRD)
- Diarrhea/ Scours
- FMD
- Clostridial Diseases
- Leptospirosis
- BVD Infection
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. LAMEA Ruminant Vaccines Market by Animal Type
Chapter 6. LAMEA Ruminant Vaccines Market by Vaccines Type
Chapter 7. LAMEA Ruminant Vaccines Market by Route of Administration
Chapter 8. LAMEA Ruminant Vaccines Market by Indication
Chapter 9. LAMEA Ruminant Vaccines Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Boehringer Ingelheim International GmbH
- Zoetis, Inc.
- Merck & Co., Inc.
- Bimeda, Inc.
- Elanco Animal Health, Inc.
- Virbac
- Ceva Sante Animale
- CZ Vaccines S.A.U. (Zendal Health S.A.)
- Indian Immunologicals Ltd. (National Dairy Development Board)
- Vaxxinova International BV (EW Group)
Methodology
LOADING...
